SKIP TO CONTENT
About Abbott
Contact
International | eng
Country Language

CARDIOVASCULAR

International | eng
Country Language

XIENCE™ Family of Drug-Eluting Stents

The World's Leading Drug-Eluting Stents (DES), with Unparalleled Clinical Outcomes¹

Unparalleled Safety

Unparalleled Safety with XIENCE™ Stent1

XIENCE™ Stent's Excellent Outcomes in Complex Patients2-4

Early outcomes with XIENCE™ Stent, implanted in complex patients, reveal excellent rates of definite stent thrombosis (ST) at 30 days:

    • Bifurcations Lesions: 0.0%2
    • Calcified Lesions: 0.0%3
    • Long Lesions: 0.3% ST4
    XIENCE Stent

    Lower Early Stent Thrombosis Rates with XIENCE™ Stent vs Other DES

    XIENCE™ Stent Acute ST Rate 75% Lower vs Other DES

    With XIENCE™ Stent there is a 75% lower rate of acute (24-hour) definite ST compared to Synergy‡.5

    Acute definite ST is 75% lower with XIENCE Stent vs Synergy: 0.3% with XIENCE Stent and 1.2% with Synergy.


    XIENCE™ Stent Early ST Rate 88% Lower vs Other DES

    With XIENCE™ Stent there is an 88% lower rate of early (30-day) definite ST compared to Resolute‡.6

    Early definite ST is 88% lower with XIENCE Stent vs Resolute: 0.1% with XIENCE Stent and 0.8% with Resolute.

    Consistently Lowest Rates of Late and Very Late Stent Thrombosis

    XIENCE™ Stent has the most exceptional rates—and consistently the lowest rates—of late and very late ST.1 It’s another example of how XIENCE™ Stent delivers unparalleled patient outcomes which last far beyond the intervention.1


    Even when examining ultra-long-term safety, XIENCE™ Stent reveals excellent patient outcomes—0.8% ST 10 years after PCI.12

    At 10 years, XIENCE Stent has revealed 0.8% stent thrombosis rates.
    Manuals & Technical Resources

    Manuals & Technical Resources

    Order Cardiovascular Products

    Cardiovascular Products

    Customer Service

    Customer Service

    References

    1. Zanchin C, et al. JACC Cardiovasc Interv. 2019;12(17):1665-1675. Serruys P, et al. N Engl J Med. 2010;363:136-146. Shiomi H, et al. JACC Cardiovasc Interv. 2019;12:637-647. Kufner S, et al. Circulation. 2019:139(3):325-333. Palmerini T, et al. Lancet. 2013;379:1393-1402. Bangalore S, et al. Circulation. 2012;125:2873-2891. Bangalore S, et al. Circ Cardiovasc Interv. 2013;6(6):378-390. Pilgrim T, et al. Lancet. 2014;384:2111-2122. Pilgrim T, et al. Lancet. 2018;392:737-746. Data on file at Abbott.
    2. Džavík V, et al. Catheter Cardiovasc Interv. 2013;82(3):E163-E172.
    3. Onuma Y, et al. Catheter Cardiovasc Interv. 2010;76:634-642.
    4. Hong S, et al. JACC Cardiovasc Interv. 2016;9:1438-1446.
    5. Zanchin C, et al. JACC Cardiovasc Interv. 2019;12(17):1665-1675.
    6. Serruys P, et al. N Engl J Med. 2010;363:136-146.
    7. von Birgelen C, et al. J Am Coll Cardiol. 2012;59:1350-1361.
    8. Natsuaki M, et al. Cardiovasc Interv Ther. 2016 31(3):196-209.
    9. van Geuns RJ, et al. TCT 2019. IDEAL-LM.
    10. Chevalier B, et al. EuroIntervention. 2018;13:1561-1564.
    11. Gao R, et al. TCT 2019. ABSORB China.
    12. Kufner S, et al. Circulation. 2019:139(3):325-333.

    MAT-2101793 v2.0

    POLICIES & ADVISORIES
    HEALTHCARE PROFESSIONALS
    PATIENTS & CAREGIVERS
    Abbott logo

    Information contained herein for distribution outside the U.S. only.

    CAUTION: These products are intended for use by or under the direction of a physician. Prior to use, reference the Instructions for Use, inside the product carton (when available) or online for more detailed information on Indications, Contraindications, Warnings, Precautions and Adverse Events.

    Illustrations are artist's representations only and should not be considered as engineering drawings or photographs.

    Unless otherwise specified, all product names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company. ™ Indicates a trademark of the Abbott group of companies. ‡ Indicates a third party trademark, which is property of its respective owner.

    © 2024 Abbott. All Rights Reserved.

    MAT-2001111 v7.0

    Disclaimer

    You are about to enter an Abbott country- or region-specific website. 

    Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions

    Do you wish to continue and enter this website? 

    YES

    MAT-2305078 v1.0